COMMUNIQUÉS West-GlobeNewswire

The Leave-of-Absence Trap in Sham Peer Review Discussed in the Journal of American Physicians and Surgeons
10/03/2026
TUCSON, Ariz., March 10, 2026 (GLOBE NEWSWIRE) -- The latest addition to the hospital sham peer review playbook for removing undesired physicians is the leave-of-absence trap, writes Lawrence R. Huntoon , M.D, Ph.D., in [...]
Longevity Based Releases New Report on Biohacking Recovery Technologies Used in CEO Jacob Gendron’s Longevity Routine
10/03/2026
Plant-based nutrition, strength training, and biohacking technology support his measured heart health. Los Angeles, CA, March 10, 2026 (GLOBE NEWSWIRE) -- Longevity Based , a Los Angeles-based wellness brand focused on [...]
Adverse Effects of COVID Vaccine on Skin Are Underrated, according to the Journal of American Physicians and Surgeons
10/03/2026
TUCSON, Ariz., March 10, 2026 (GLOBE NEWSWIRE) -- The skin-related adverse effects of COVID vaccines have been dismissed as “irrelevant” by experts and overlooked by the public, writes Jane M. Orient, M.D ., in the [...]
Galapagos Receives Transparency Notifications from Bank of America
10/03/2026
Mechelen, Belgium ; March 10, 2026, 22:01 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) received transparency notifications from Bank of America. Pursuant to Belgian transparency legislation 1 [...]
To Restore Trust, Doctors Need to Re-commit to the Oath of Hippocrates, according to the Journal of American Physicians and Surgeons
10/03/2026
TUCSON, Ariz., March 10, 2026 (GLOBE NEWSWIRE) -- The medical profession has traded its birthright for a mess of pottage called evidence-based medicine, writes Stephen Hughes, M.D., in the spring issue of the Journal of [...]
Medicare Advantage Mental Health Coverage in New York: $0–$30 Online Therapy Sessions
10/03/2026
Manhattan Mental Health Counseling, the highest-rated affordable online therapy practice is now in-network with five major Medicare Advantage carriers. They now cover 78% of the state’s 1.8 million beneficiaries. NEW [...]
R1 and Heidi Announce Strategic Partnership to Improve Revenue Capture for Physician Groups and Healthcare Organizations
10/03/2026
Partnership Integrates Heidi’s AI scribe technology into R1’s Phare Revenue Operating System, Bringing Reimbursement Accuracy into the Clinical Workflow CHICAGO and NEW YORK, March 10, 2026 (GLOBE NEWSWIRE) -- R1, the [...]
TELA Bio to Announce Fourth Quarter and Full Year 2025 Financial Results
10/03/2026
MALVERN, Pa., March 10, 2026 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today [...]
Skye Bioscience Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
10/03/2026
Initiated higher-dose CBeyond Expansion Study (Part C) to generate higher-exposure human safety and pharmacokinetic data with 400 mg and 600 mg IV cohorts; Received written FDA Type C meeting minutes; feedback is [...]
Fortrea Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
10/03/2026
DURHAM, N.C., March 10, 2026 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization, today announced the granting of an inducement award of restricted stock units (“ [...]
Trevi Therapeutics to Report Fourth Quarter and Year End 2025 Financial Results and Provide Business Updates on March 17, 2026
10/03/2026
Conference call and webcast to be held at 4:30 p.m. ET NEW HAVEN, Conn., March 10, 2026 (GLOBE NEWSWIRE) -- Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company developing the [...]
Artiva Biotherapeutics Reports Full Year 2025 Financial Results and Recent Business Highlights
10/03/2026
Initial clinical response data for AlloNK ® in refractory rheumatoid arthritis (RA) expected in first half of 2026 U.S. Food and Drug Administration (FDA) interaction to discuss potential pivotal trial design for AlloNK [...]
vTv Therapeutics Announces Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
10/03/2026
Received $20.0 million in February 2026 from Newsoara under an amended licensing agreement Expect to complete enrollment in the CATT1 Phase 3 trial in the third quarter of 2026 Strengthened balance sheet provides [...]
Rapid Micro Biosystems to Participate in KeyBanc Capital Markets Healthcare Forum
10/03/2026
LEXINGTON, Mass., March 10, 2026 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to [...]
Lifecore Biomedical to Participate in 6th Annual KeyBanc Capital Markets Healthcare Virtual Forum
10/03/2026
CHASKA, Minn., March 10, 2026 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR ) (“Lifecore”), a fully integrated injectables contract development and manufacturing organization (“CDMO”), today announced that [...]
Lifeward to Report Fourth Quarter and Full Year 2025 Financial Results on March 18, 2026
10/03/2026
MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, March 10, 2026 (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global leader in innovative medical technology to transform the lives of [...]
SIGA Reports Financial Results for Three and Twelve Months Ended December 31, 2025 and Provides Business Update
10/03/2026
Generated TPOXX Product Revenues of $88 Million in 2025 Received $13 Million International Procurement Order for Oral TPOXX in January 2026 Corporate Update Conference Call Today at 4:30 PM ET NEW YORK, March 10, 2026 ( [...]
BioXcel Therapeutics Announces Approximately $8.0 Million Registered Direct Offering
10/03/2026
NEW HAVEN, Conn., March 10, 2026 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (the “Company”) (Nasdaq: BTAI), a biopharmaceutical company built on artificial intelligence to develop transformative medicines in [...]
Acumen Pharmaceuticals to Participate in the Stifel 2026 Virtual CNS Forum
10/03/2026
NEWTON, Mass., March 10, 2026 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing novel therapeutics that target toxic soluble amyloid beta oligomers [...]

Pages